Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance
Radheshyam Meher, Senior Resident at AIIMS, psoted on LinkedIn:
”Exciting Announcement
I am honored to serve as Guest Editor for a special collection in Cureus on:
“Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance”
This collection will highlight how AI is reshaping every step of the transfusion medicine journey, from innovative donor recruitment and retention strategies to predictive inventory management, AI-driven blood safety and pathogen detection, automated hemovigilance, and advanced clinical decision support.
We welcome original research, reviews, case studies, and perspectives that showcase both technological innovation and real-world applications, while also addressing the ethical and regulatory challenges of AI in healthcare.
Our aim is to bring together a global, interdisciplinary perspective that bridges digital health, transfusion science, and clinical practice, ultimately driving improvements in efficiency, safety, and patient outcomes.
Topics include (but are not limited to):
- AI for donor recruitment and retention
- Predictive analytics for transfusion needs
- Machine learning in inventory management
- Automated hemovigilance and adverse event monitoring
- AI in therapeutic apheresis and cellular therapies
- NLP in transfusion data
- Ethical and regulatory considerations
I invite researchers, clinicians, data scientists, and innovators to submit your work and be part of this forward-looking initiative.
Let’s work together to shape the future of AI in Transfusion Medicine.
Submit here.”
Stay updated with Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome